Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00992199Phase 2Unknown
Phase 2, randomised, open-label trial of cisplatin and fluorouracil in gastric cancer (GC) (2 arms), sponsored by Fudan University. Primary endpoint: Metastasis in Peritoneum and peritoneal cavity at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00992199.